Identification and validation of ferroptosis-related genes for diabetic nephropathy
European Journal of Pharmacology · 2026-03 · 1019 · 178779
DOI: 10.1016/j.ejphar.2026.178779 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2026-03. Verfasst von Hao Duan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The Second Affiliated Hospital of Anhui Medical University, No. 678 Furong Road, Jingkai District, Hefei, 230601, Anhui …. Hauptthemen laut MEDLINE: Ferroptosis, Diabetic Nephropathies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Anhui Province Department of Education, Anhui Yike Daxue, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Emerging evidence highlights the pivotal role of ferroptosis in the pathophysiology of diabetic nephropathy (DN). This study aimed to identify potential ferroptosis-related genes (FRGs) in DN through bioinformatics and experimental validation. METHODS: Datasets for diabetic nephropathy (DN) and ferroptosis-related gene sets were obtained from the Gene Expression Omnibus (GEO) database and the Ferroptosis Database, respectively. Differential expression analysis identified ferroptosis-related genes (DE-FRGs) in DN, and machine learning was applied to screen key genes. The risk model's accuracy was evaluated using receiver operating characteristic (ROC) curve analysis. Potential small chemical compounds associated with DE-FRGs and DN were also explored. Expression of DE-FRGs was measured by Quantitative Reverse Transcription PCR (qRT-PCR) in kidneys of DN mice and by Enzyme-linked immunosorbent assay (ELISA) in serum from DN patients versus non-DN controls. RESULTS: Analysis identified 125 DE-FRGs enriched in ferroptosis and DN-related pathways. Machine learning pinpointed nine diagnostic biomarkers, which were validated by ROC curves, and 13 potential therapeutic compounds. Among the DE-FRGs, qRT-PCR verified dysregulation of interleukin-33 (IL-33), retinoic acid receptor responder protein 2 (RARRES2), enhancer of zeste homolog 2 (EZH2), gap junction protein alpha 1 (GJA1), and hypoxia-inducible lipid droplet associated (HILPDA) in DN kidneys. Importantly, serum levels of EZH2 and IL-33 were significantly elevated in DN patients, underscoring their critical role in pathogenesis and potential as therapeutic targets. CONCLUSIONS: In conclusion, this study identified IL-33 and EZH2 as key DE-FRGs in DN, offering new insights into the molecular mechanisms underlying the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, The Second Affiliated Hospital of Anhui Medical University, No. 678 Furong Road, Jingkai District, Hefei, 230601, Anhui Province, China; Research Center for Translational Medicine, The Secon…
Förderung
- Anhui Province Department of Education
- Anhui Yike Daxue
- National Natural Science Foundation of China
Zitieren
APA
Duan, H., Wang, Y., Wang, Q., Yan, J., Fan, X., Wu, W., Zhong, X., Wang, Y., Pan, T., & Du, Y. (2026). Identification and validation of ferroptosis-related genes for diabetic nephropathy. European Journal of Pharmacology, 1019, 178779. https://doi.org/10.1016/j.ejphar.2026.178779
Vancouver
Duan H, Wang Y, Wang Q, Yan J, Fan X, Wu W, et al. Identification and validation of ferroptosis-related genes for diabetic nephropathy. European Journal of Pharmacology. 2026;1019:178779. doi:10.1016/j.ejphar.2026.178779
BibTeX
@article{Duan2026,
author = {Duan, Hao and Wang, Yanqiu and Wang, Qiao and Yan, Jie and Fan, Xingyu and Wu, Wenyan and Zhong, Xing and Wang, Yue and Pan, Tianrong and Du, Yijun},
title = {Identification and validation of ferroptosis-related genes for diabetic nephropathy},
journal = {European Journal of Pharmacology},
year = {2026},
volume = {1019},
pages = {178779},
doi = {10.1016/j.ejphar.2026.178779}
}
EUVIMED